glp-1 sleep apnea trial Ozempic and apnea: What the new research shows Sleep Apnea, GLP-1 Medications &

A multicenter prospective study (Dao et al., 2024) followed 168 pregnancies with first-trimester GLP-1 exposure

In the obesity trial, proportions of subjects reporting nausea were 14-60% with retatrutide versus 11% with placebo [3]

The capacity of GLP-1 RAs to decelerate gastric emptying to levels indicative of gastroparesis raises concerns regarding potential intestinal obstruction and perioperative aspiration risk

It can be observed that proglucagon is not expressed by a single gene, but is embedded in a larger gene, and when this large gene expresses a large peptide chain (called preprohormones), it is then cleaved by specific enzymes and post-translationally modified to finally obtain fragments with different biological activities